Cargando…
Pharmacogenomic Analysis of Combined Therapies against Glioblastoma Based on Cell Markers from Single-Cell Sequencing
Glioblastoma is the most common and aggressive form of primary brain cancer and the lack of viable treatment options has created an urgency to develop novel treatments. Personalized or predictive medicine is still in its infancy stage at present. This research aimed to discover biomarkers to inform...
Autores principales: | Liu, Junying, Wu, Ruixin, Yuan, Shouli, Kelleher, Robbie, Chen, Siying, Chen, Rongfeng, Zhang, Tao, Obaidi, Ismael, Sheridan, Helen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10675611/ https://www.ncbi.nlm.nih.gov/pubmed/38004399 http://dx.doi.org/10.3390/ph16111533 |
Ejemplares similares
-
ESR1 dysfunction triggers neuroinflammation as a critical upstream causative factor of the Alzheimer’s disease process
por: Liu, Junying, et al.
Publicado: (2022) -
Network Pharmacology and Molecular Docking Elucidate the Underlying Pharmacological Mechanisms of the Herb Houttuynia cordata in Treating Pneumonia Caused by SARS-CoV-2
por: Liu, Junying, et al.
Publicado: (2022) -
Whole genome sequencing in pharmacogenomics
por: Katsila, Theodora, et al.
Publicado: (2015) -
Pharmacogenomics of Scopoletin in Tumor Cells
por: Seo, Ean-Jeong, et al.
Publicado: (2016) -
Pharmacogenomic markers of glucocorticoid response in congenital adrenal hyperplasia
por: Botelho Barra, Cristina, et al.
Publicado: (2022)